Nasdaq, Inc. (NASDAQ:NDAQ – Get Rating)’s share price gapped down prior to trading on Wednesday following a dissappointing earnings announcement. The stock had previously closed at $61.92, but opened at $58.95. Nasdaq shares last traded at $57.54, with a volume of 739,542 shares trading hands.
The financial services provider reported $0.64 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.01). The firm had revenue of $906.00 million during the quarter, compared to analysts’ expectations of $908.94 million. Nasdaq had a net margin of 18.72% and a return on equity of 22.08%. Nasdaq’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.64 earnings per share.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. Oppenheimer upped their target price on shares of Nasdaq from $65.00 to $71.00 in a research note on Wednesday, November 9th. UBS Group cut shares of Nasdaq to a “neutral” rating in a report on Tuesday, November 15th. Morgan Stanley upped their price target on shares of Nasdaq from $72.00 to $73.00 and gave the company an “overweight” rating in a report on Friday, January 20th. Rosenblatt Securities upped their price target on shares of Nasdaq from $80.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, October 20th. Finally, The Goldman Sachs Group upped their price target on shares of Nasdaq from $50.00 to $55.00 and gave the company a “sell” rating in a report on Monday, November 28th. Two analysts have rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, Nasdaq has an average rating of “Hold” and an average price target of $67.38.
Insiders Place Their Bets
Institutional Trading of Nasdaq
Hedge funds have recently made changes to their positions in the stock. Eqis Capital Management Inc. raised its position in Nasdaq by 187.5% during the third quarter. Eqis Capital Management Inc. now owns 9,373 shares of the financial services provider’s stock valued at $531,000 after acquiring an additional 6,113 shares in the last quarter. Sheaff Brock Investment Advisors LLC raised its position in shares of Nasdaq by 197.8% in the third quarter. Sheaff Brock Investment Advisors LLC now owns 4,050 shares of the financial services provider’s stock valued at $230,000 after purchasing an additional 2,690 shares during the period. Apollon Wealth Management LLC bought a new position in shares of Nasdaq in the second quarter valued at approximately $265,000. Canandaigua National Corp raised its position in shares of Nasdaq by 185.2% in the third quarter. Canandaigua National Corp now owns 13,942 shares of the financial services provider’s stock valued at $790,000 after purchasing an additional 9,053 shares during the period. Finally, Aviva PLC raised its position in shares of Nasdaq by 16.6% in the second quarter. Aviva PLC now owns 33,661 shares of the financial services provider’s stock valued at $5,135,000 after purchasing an additional 4,793 shares during the period. 73.01% of the stock is owned by hedge funds and other institutional investors.
Nasdaq Stock Performance
The company has a market cap of $28.32 billion, a P/E ratio of 25.20, a price-to-earnings-growth ratio of 5.44 and a beta of 0.96. The company has a quick ratio of 0.95, a current ratio of 0.96 and a debt-to-equity ratio of 0.78. The stock’s 50-day moving average price is $63.58 and its 200 day moving average price is $60.90.
About Nasdaq
Nasdaq, Inc is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Market Technology, Investment Intelligence, Corporate Platforms, and Market Services.
Further Reading
- Get a free copy of the StockNews.com research report on Nasdaq (NDAQ)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- Is It Time To Get Aggressive With Defense Stocks?
Receive News & Ratings for Nasdaq Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nasdaq and related companies with MarketBeat.com's FREE daily email newsletter.